Articles
RSSAcceleron Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy
August 19, 2010
- Pharmaceutical Online The Magazine
- 2011 Edition
- 2010 Edition
- 2009 Edition
- Resource Centers
- Clinical Trials
- Single-Use
- Find BioPharm Solutions
- Assay
- Assay Development
- Bioanalytical Methods
- Biopharmaceutical Contract Manufacturing
- Bioprocessing
- Bioreactors
- Biosafety Cabinet
- Capillary Electrophoresis
- Cell Culture
- Centrifuge
- Chemicals
- Chromatography
- Cleaning
- Cleanroom
- Clinical
- Columns
- Contract Manufacturing
- Contract Services
- Contract Testing
- Diagnostics
- Downstream Processing
- Equipment Service
- Fermentation
- Fill Finish
- Filtration
- Filters
- Formulation
- Freeze Dryers
- HPLC
- Homogenizer
- Hydrolysates
- Incubator
- Lab Centrifuge
- Label Free Protein Interaction Analysis
- LIMS
- Lyophilizer
- Media
- Microbial
- Monoclonal Antibodies
- Oligos
- Outsourcing
- PCR
- Peptides
- Process Development
- Proteins
- Purification
- Quality Issues
- RNA
- Separation
- Single Use
- Software
- Stainless Steel Hand Tools
- Therapeutics
- Validation
- Washers
- News and Information
- Current Headlines
- White Papers and Case Studies
- Product Showcase
- Newsletters
- Events
- Market Research Reports
- Industry Associations
- Services
Copyright © 1996 - 2012, VertMarkets, Inc. All rights reserved.